Jackson Financial Inc.
JXN
$116.28
-6.04%
Jackson Financial Inc. is a life insurance company specializing in retirement savings and income products, primarily annuities, serving the U.S. market. As a leading provider of variable, fixed index, and fixed annuities, it holds a distinct position in the retirement income space, with its Retail Annuities segment generating the majority of revenue. The current investor narrative centers on the company's ability to navigate a volatile interest rate environment and equity market fluctuations, which directly impact its annuity liabilities and investment spreads, while also focusing on capital return initiatives and balance sheet optimization.…
JXN
Jackson Financial Inc.
$116.28
Investment Opinion: Should I buy JXN Today?
Rating: Hold. The thesis is that Jackson Financial offers a compelling forward valuation and strong cash generation, but near-term profitability challenges and revenue volatility warrant caution. The analyst consensus is 'Buy' with an average target of $134.25, implying modest upside.
Supporting Evidence: The forward P/E of 4.48x is very low, suggesting undervaluation if earnings normalize. Revenue growth is negative (-22.05% YoY), but free cash flow remains robust at $1.045 billion in Q1 2026, yielding 13.9% relative to market cap. The dividend yield of 3.57% is attractive, and the payout ratio of 9.89% indicates sustainability. However, the negative trailing P/E and ROE of 0.27% highlight current weakness.
Risks & Conditions: The biggest risks are continued revenue decline and margin compression. This Hold would upgrade to Buy if the company reports a return to positive net income and revenue growth stabilizes above 5%. It would downgrade to Sell if free cash flow deteriorates significantly or if the forward P/E expands above 8x without earnings improvement. Overall, the stock appears fairly valued relative to its current earnings power but undervalued on a forward basis if the recovery materializes.
Sign up to view all
JXN 12-Month Price Forecast
The outlook for Jackson Financial is balanced between the potential for earnings recovery and the risk of continued losses. The low forward P/E and strong cash flow provide a margin of safety, but the negative trailing earnings and revenue decline are concerning. The base case of modest upside to the average target is most likely, but the stock's high beta means it could swing significantly in either direction. Upgrading to bullish would require a clear earnings turnaround, while downgrading to bearish would follow further deterioration in revenue and margins.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Jackson Financial Inc.'s 12-month outlook, with a consensus price target around $134.25 and implied upside of +15.4% versus the current price.
Average Target
$134.25
0 analysts
Implied Upside
+15.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$128 - $140
Analyst target range
Jackson Financial is covered by 4 analysts, with a consensus recommendation of 'Buy' (mean rating 2.25 on a 1-5 scale, where 1 is Strong Buy). The average target price is $134.25, implying approximately 6.8% upside from the current price of $125.66. The distribution leans bullish, with no sell ratings. The target range spans from a low of $128.00 to a high of $140.00. The high target of $140.00 assumes continued momentum, potential earnings recovery, and successful capital return, while the low target of $128.00 factors in margin pressures and revenue volatility. Recent ratings actions include Jefferies upgrading from Hold to Buy on July 10, 2026, and Barclays maintaining Overweight, indicating positive sentiment. The spread between low and high targets is $12.00 (9.4% of the average), reflecting moderate uncertainty. The limited analyst coverage (4 analysts) is typical for a mid-cap insurance company, which can lead to less efficient price discovery and higher volatility compared to larger peers.
Drowning in data?
Find the real signal!
Bulls vs Bears: JXN Investment Factors
Jackson Financial presents a mixed picture: strong cash generation, attractive forward valuation, and positive analyst sentiment contrast with declining revenues, negative earnings, and margin compression. The bull case rests on the company's ability to normalize earnings and return capital to shareholders, supported by a low forward P/E and high FCF yield. The bear case highlights the risk of sustained profitability issues and revenue volatility. The single most important tension is whether the company can reverse its revenue decline and restore margins to historical levels; if it does, the stock could be significantly undervalued, but if not, the current valuation may be justified. Currently, the bull case has slightly stronger evidence given the low forward P/E and strong cash flow, but the risks are substantial.
Bullish
- Strong capital return and cash generation: Jackson Financial has a dividend yield of 3.57% and a payout ratio of 9.89%, indicating ample room for dividend growth. Free cash flow was $1.045 billion in Q1 2026, and the FCF yield is approximately 13.9%, demonstrating robust cash generation relative to market cap.
- Attractive valuation on forward earnings: The forward P/E ratio is 4.48x based on estimated EPS of $34.75, which is very low compared to the broader market. If earnings normalize, the stock could be significantly undervalued, offering substantial upside potential.
- Positive analyst sentiment and upside potential: Analysts have a consensus 'Buy' rating with an average target price of $134.25, implying 6.8% upside from the current price of $125.66. The high target of $140.00 suggests further upside of 11.4%, and recent upgrades (Jefferies from Hold to Buy) indicate improving sentiment.
- Strong price momentum and relative strength: The stock has gained 41.94% over the past year, significantly outperforming the S&P 500's 18.35% gain. The 1-month relative strength is 15.62%, and the stock is near its 52-week high, reflecting strong bullish momentum.
Bearish
- Declining revenue and profitability issues: Revenue in Q1 2026 was $2.902 billion, down 22.05% year-over-year. The company reported a net loss of $424 million in Q1 2026, and gross margin collapsed from 85.47% to 22.09% over the same period, indicating severe margin compression.
- Negative trailing earnings and ROE: Trailing P/E is negative at -444.38x due to net losses. Return on equity (ROE) was only 0.27% in Q1 2026, well below historical levels, signaling weak profitability relative to equity capital.
- High volatility and near-term overextension: With a beta of 1.331, the stock is 33.1% more volatile than the market. The current price is at 99.2% of its 52-week range, suggesting the stock may be overextended and vulnerable to profit-taking.
- Uncertain earnings recovery path: The company has been unprofitable in three of the last four quarters, with net income swinging wildly. The negative operating margin of -13.78% in Q1 2026 indicates ongoing operational challenges, and the path to consistent profitability is unclear.
JXN Technical Analysis
Jackson Financial is in a strong uptrend, with the stock price up 41.94% over the past year, significantly outperforming the S&P 500's 18.35% gain. The current price of $125.66 sits at 99.2% of its 52-week range (high $126.69, low $82.65), indicating the stock is near its peak and reflecting robust momentum. This positioning near highs suggests bullish sentiment but also raises caution about potential overextension, as the stock has rallied sharply from its lows. Short-term momentum is accelerating, with a 1-month price change of +15.93% and a 3-month change of +14.56%, both outpacing the S&P 500's respective gains of 0.31% and 4.67%. The relative strength index (RSI) is not directly provided, but the strong price action and volume of 620,425 shares suggest active buying interest. The 1-month trend aligns with the longer-term uptrend, reinforcing the bullish narrative, though the rapid ascent could invite profit-taking. The 52-week low of $82.65 serves as key support, while the 52-week high of $126.69 is immediate resistance. A breakout above $126.69 would signal further upside, potentially targeting new highs, while a breakdown below $82.65 would indicate a trend reversal. The stock's beta of 1.331 implies it is 33.1% more volatile than the market, meaning it amplifies market moves—a factor for risk management.
Beta
1.33
1.33x market volatility
Max Drawdown
-17.0%
Largest decline past year
52-Week Range
$83-$127
Price range past year
Annual Return
+30.0%
Cumulative gain past year
| Period | JXN Return | S&P 500 |
|---|---|---|
| 1m | +5.8% | +0.6% |
| 3m | +2.8% | +3.4% |
| 6m | +2.6% | +7.1% |
| 1y | +30.0% | +16.4% |
| ytd | +8.2% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
JXN Fundamental Analysis
Revenue trajectory is volatile and declining, with the most recent quarter (Q1 2026) reporting $2.902 billion, down 22.05% year-over-year from $3.723 billion in Q1 2025. Over the trailing four quarters, revenue has fluctuated significantly: Q4 2025 at $2.094 billion, Q3 2025 at $1.349 billion, and Q2 2025 at -$483 million (negative due to accounting adjustments). The Retail Annuities segment contributed $1.411 billion, Institutional Products $148 million, and Closed Life and Annuity Blocks $318 million in the most recent period. The declining revenue trend raises concerns about top-line sustainability, though the negative Q2 2025 figure is an anomaly. Profitability is inconsistent; the company reported a net loss of $424 million in Q1 2026, compared to a net loss of $24 million in Q1 2025. Gross margin was 22.09% in Q1 2026, down from 85.47% in the prior year quarter, indicating margin compression. Operating margin was -13.78%, reflecting operating losses. The company has been unprofitable in three of the last four quarters, with net income swinging from positive $345 million in Q4 2024 to losses in subsequent quarters. The balance sheet shows a debt-to-equity ratio of 0.463, which is moderate for the insurance industry. Free cash flow (FCF) was $1.045 billion in Q1 2026, down from $1.594 billion in Q1 2025, but still robust. The company has $5.539 billion in cash, providing ample liquidity. Return on equity (ROE) was 0.27% in the most recent quarter, well below historical levels, indicating weak profitability relative to equity. The FCF yield (FCF/market cap) is approximately 13.9%, suggesting strong cash generation relative to market value.
Quarterly Revenue
$2.9B
2026-03
Revenue YoY Growth
-22.1%
YoY Comparison
Gross Margin
22.1%
Latest Quarter
Free Cash Flow
$5.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is JXN Overvalued?
Since net income is negative (trailing twelve months net loss), the price-to-sales (PS) ratio is the primary valuation metric. The trailing PS ratio is 1.12x, while the forward PS ratio is not directly available but can be estimated from revenue estimates. The low PS ratio reflects the company's depressed earnings and revenue challenges. Compared to the industry average PS ratio (not provided, but typically for life insurance companies, PS ratios range from 0.5x to 2x), Jackson's 1.12x is near the midpoint, suggesting it is not excessively overvalued on a sales basis. However, the negative earnings make traditional PE analysis uninformative. Historically, Jackson's PS ratio has ranged from 0.34x (in mid-2022) to 5.87x (in mid-2023), with the current 1.12x near the lower end of its historical range. This suggests the stock is trading at a discount to its own historical sales multiple, potentially indicating undervaluation or reflecting the recent deterioration in profitability. The price-to-book (PB) ratio of 0.75x is below 1.0, implying the stock trades below its book value, which is common for insurance companies with low ROE. The forward PE ratio of 4.48x (based on estimated EPS of $34.75) suggests that if earnings normalize, the stock could be cheap, but the negative trailing earnings highlight the uncertainty.
PE
-444.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 0x~9x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-455.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Jackson Financial faces significant financial risks from its volatile revenue and profitability. Revenue declined 22.05% year-over-year in Q1 2026, and the company reported a net loss of $424 million, with gross margin plummeting from 85.47% to 22.09%. The negative operating margin of -13.78% indicates operational inefficiencies, and the debt-to-equity ratio of 0.463, while moderate, could become problematic if earnings remain depressed. The company's reliance on annuity products exposes it to interest rate and equity market fluctuations, which can cause large swings in liabilities and investment spreads.
Market & Competitive Risks: The stock's beta of 1.331 implies higher volatility than the market, making it sensitive to macro shocks. Valuation compression is a risk if the forward P/E of 4.48x expands due to earnings disappointment, but the low multiple already reflects pessimism. Competitive pressures from other life insurers and asset managers could erode market share. Regulatory changes affecting annuity products or tax treatment of retirement savings could also pose headwinds. The limited analyst coverage (4 analysts) may lead to less efficient price discovery and higher volatility.
Worst-Case Scenario: In a severe downturn, if the company continues to report losses and revenue declines accelerate, the stock could fall to its 52-week low of $82.65, representing a -34.2% decline from the current price of $125.66. This scenario could be triggered by a prolonged bear market in equities, rising interest rates compressing spreads, or a credit event. The historical max drawdown of -17.03% provides a reference, but given the current near-peak valuation, a larger decline is possible.
FAQ
The key risks are: 1) Financial risk: revenue declined 22.05% YoY and the company reported a net loss of $424 million in Q1 2026, with gross margin falling from 85.47% to 22.09%. 2) Valuation risk: the negative trailing P/E and low ROE (0.27%) indicate weak current profitability. 3) Market risk: with a beta of 1.331, the stock is highly volatile and sensitive to equity market movements. 4) Company-specific risk: reliance on annuity products exposes the company to interest rate and regulatory changes. The most severe risk is a continued earnings decline, which could lead to a -34.2% drop to the 52-week low.
The 12-month forecast is mixed. The bull case (30% probability) sees the stock reaching $134.25-$140.00, driven by earnings recovery and multiple expansion. The base case (45% probability) expects the stock to trade between $125.66 and $134.25, with modest upside. The bear case (25% probability) could see the stock fall to $82.65-$100.00 if losses persist. The most likely scenario is the base case, assuming revenue stabilizes and margins improve. Analysts are optimistic, with a consensus 'Buy' and average target of $134.25.
JXN appears undervalued on a forward earnings basis, with a forward P/E of 4.48x, which is low relative to the broader market. The price-to-book ratio of 0.75x indicates the stock trades below book value, common for insurers with low ROE. The trailing P/E is negative due to losses, so traditional valuation metrics are distorted. Compared to its own history, the current PS ratio of 1.12x is near the lower end of its historical range (0.34x to 5.87x), suggesting it is not overvalued on a sales basis. The market is pricing in continued earnings weakness, but if earnings normalize, the stock could be significantly undervalued.
JXN offers a compelling risk/reward for investors with a high risk tolerance. The stock has a forward P/E of 4.48x, a dividend yield of 3.57%, and a free cash flow yield of 13.9%, suggesting it is undervalued if earnings recover. However, the company reported a net loss of $424 million in Q1 2026 and revenue declined 22.05% YoY, indicating significant near-term challenges. Analysts have a 'Buy' consensus with an average target of $134.25, implying 6.8% upside. The biggest downside risk is continued losses, which could push the stock to its 52-week low of $82.65 (-34.2%). For investors who believe in a turnaround, it could be a good buy; for those seeking stable earnings, it is not.
JXN is more suitable for long-term investment given its speculative nature and high volatility (beta 1.331). Short-term trading is risky due to the stock's nearness to its 52-week high and potential for profit-taking. The dividend yield of 3.57% provides income for long-term holders, and the low forward P/E suggests potential for capital appreciation if the turnaround materializes. A minimum holding period of 2-3 years is recommended to allow for earnings normalization. However, investors should be prepared for significant price swings along the way.
